Depressive Disorder: all 4,846 studies

Page 40 of 49. Open to participants first (508), then studies with results posted, then the rest; newest registration first within each.

• Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate ResponseCompletedNCT01397903
• Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCompletedNCT01395147Phase 3
• Treatment Resistant Geriatric Depression in Primary CareCompletedNCT01392287Phase 1
• Inflammatory Markers and Cognitive Function in Major DepressionStatus unknownNCT01391221Phase 4
• Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With DepressionStatus unknownNCT01390662Phase 4
• Aripiprazole and Resistant Postpartum DepressionCompletedNCT01386086Phase 3
• The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsCompletedNCT01385709
• Holistic Approaches to DepressionCompletedNCT01384916Phase 2
• Exercise in Treatment Resistant Depression (TRD): A Feasibility StudyCompletedNCT01383811Not applicable
• ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDDCompletedNCT01381107Phase 1/2
• Safety and Pharmacodynamic Study of ABT-436 in Major Depressive DisorderCompletedNCT01380704Phase 1
• Neighborhoods, Networks, Depression, and HIV RiskCompletedNCT01380613Phase 2
• MoodHelper: Internet Cognitive Behavioral Therapy (CBT) for DepressionCompletedNCT01379027Not applicable
• The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription BehavioursCompletedNCT01377896
• Antiglucocorticoid Augmentation of antiDepressants in DepressionCompletedNCT01375920Phase 3
• Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive DisorderStatus unknownNCT01370304Phase 3
• Electroencephalography (EEG) Signal ProcessingStatus unknownNCT01369290
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionCompletedNCT01369095Phase 2
• Investigation of Tibolone and Escitalopram in Perimenopausal DepressionTerminatedNCT01368068Phase 4
• The Quietude Study: Quetiapine Use for Agitated DepressionTerminatedNCT01363310Phase 3
• Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)CompletedNCT01361815Not applicable
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionTerminatedNCT01361555Phase 2
• Validation of the Spanish Version of the Clinically Useful Depression Outcome Scale (CUDOS) ScaleCompletedNCT01360307
• Neurophysiologic Monitoring of Antidepressant TreatmentCompletedNCT01360190Phase 4
• The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude SlopeStatus unknownNCT01357967Phase 4
• Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant DepressionCompletedNCT01353092Phase 3
• Behavioral Depression Treatment for African American HIV-infected Substance UsersCompletedNCT01351454Not applicable
• Health Care Management for the Elderly in Community Through ScreeningCompletedNCT01347138Not applicable
• A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)CompletedNCT01344733
• Trigeminal Nerve Stimulation for Depression: Dose FindingCompletedNCT01343563Phase 2
• African American Depression Intervention Trial (AADI)CompletedNCT01342536Phase 3
• Pioglitazone and Quetiapine XR Pharmacogenetic StudyCompletedNCT01342380
• PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
• Omega-3 and Therapy Study for DepressionCompletedNCT01341925Phase 1
• A Study of Mood and Stress After Spinal Cord InjuryCompletedNCT01337908
• Trigeminal Nerve Stimulation for Post Traumatic Stress Disorder (PTSD) and DepressionCompletedNCT01335217Phase 1
• Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive DisorderCompletedNCT01330485Not applicable
• TeamCare PCN: Collaborative Care for Diabetes and DepressionCompletedNCT01328639Not applicable
• A Prospective Study of Postpartum Depression in Women With Major DepressionTerminatedNCT01328613
• Cortical/Subcortical Circuits in Late-Life DepressionCompletedNCT01327417
• Myelin, Glia and Depression in Type 2 DiabetesCompletedNCT01327404
• Internet-Based Depression Screening for College StudentsCompletedNCT01326793Not applicable
• Changes of Functional Connectivity After rTMS in DepressionCompletedNCT01325831Phase 4
• Internet-delivered Psychodynamic Therapy for DepressionCompletedNCT01324050Not applicable
• Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's DiseaseCompletedNCT01323699Phase 1/2
• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)CompletedNCT01318434Phase 2/3
• Suicidal Ideation and Behavior in Korean Adolescents With DepressionStatus unknownNCT01314521
• Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderWithdrawnNCT01313403Not applicable
• Mothers Avoiding Depression Through Empowerment Intervention TrialCompletedNCT01312883Not applicable
• Epidemiology and Prevention of Anxiety and Depression in Parents of Hospitalized NeonatesCompletedNCT01310634Not applicable
• Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNCT01310140
• Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionCompletedNCT01309945Phase 2
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive DisorderCompletedNCT01309776Phase 4
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
• Randomised Control Trial of a Complex Intervention for Postnatal DepressionCompletedNCT01309516Phase 2
• Study of Quality of Life in Freeman-Sheldon Syndrome and Related ConditionsTerminatedNCT01307475
• The Use of Ketamine as an Anaesthetic During Electroconvulsive TherapyCompletedNCT01306760Phase 4
• The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed EldersCompletedNCT01305889Not applicable
• Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major DepressionTerminatedNCT01305707Phase 4
• Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ DepressionCompletedNCT01303601Phase 4
• Preventing Maternal Depression In Head StartCompletedNCT01298804Not applicable
• Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive DisorderCompletedNCT01292889
• Italian Network for the Improvement of Compliance in DepressionStatus unknownNCT01292499Not applicable
• Depression Care Management for Depressed Elders in China Primary CareStatus unknownNCT01287494Phase 4
• Feasibility and Acceptability of an Educational Intervention to Improve the Management of Depression in Primary Care.CompletedNCT01284803Not applicable
• Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)CompletedNCT01284218
• Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
• The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke PatientsStatus unknownNCT01278498Phase 4
• Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)CompletedNCT01277432
• Safety and Efficacy of RX-10100 to Treat Major Depressive DisorderCompletedNCT01273376Phase 2
• DBS in Treatment Resistant Major DepressionStatus unknownNCT01268137Phase 3
• Treatment of Conduct Problems and DepressionStatus unknownNCT01267773Phase 1
• Tai Chi Training for Treating Depressed Chinese AmericansCompletedNCT01263730Not applicable
• Trial of Transcranial Direct Current Stimulation (tDCS) for DepressionCompletedNCT01263275Phase 2
• A Study of LY2940094 in Major Depressive DisorderCompletedNCT01263236Phase 1
• Pharmacogenetic-Directed Treatment for Major DepressionCompletedNCT01261364Not applicable
• Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-upCompletedNCT01255982
• Prenatal Depression and Failure to BreastfeedWithdrawnNCT01252602
• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant DepressionCompletedNCT01246908Phase 2
• Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental IllnessCompletedNCT01244854Not applicable
• Depression and Anxiety in the Aetiology and Prognosis of Specific Cardiovascular Disease Syndromes: a CALIBER StudyStatus unknownNCT01240798
• Effectiveness of Theta-burst Stimulation (TBS) in Patients With Major DepressionCompletedNCT01240083Not applicable
• Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot StudyStatus unknownNCT01239888Phase 1
• Universal Screening for Maternal Depression With the CHICA SystemCompletedNCT01238614Not applicable
• Fish Oil Supplementation in Late-life DepressionCompletedNCT01235533Not applicable
• Single IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionCompletedNCT01234558Phase 2
• Mindfulness and Lifestyle Interventions for Depression and Anxiety: A Pilot StudyStatus unknownNCT01230047Not applicable
• Primary Care Internet-Based Depression Prevention for Adolescents (CATCH-IT)WithdrawnNCT01228890Phase 3
• Online Self-help for Depressed Patients Awaiting PsychotherapyTerminatedNCT01226238Not applicable
• Rumination-focused CBT Training for the Prevention of Depression and AnxietyCompletedNCT01223677Phase 1
• Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive DisorderCompletedNCT01221935
• Treatment of Depression in Mothers in Home VisitationCompletedNCT01221701Not applicable
• Middle School Matters StudyCompletedNCT01220635Not applicable
• EScitalopram PIndolol ONset of ActionTerminatedNCT01219686Phase 2/3
• Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous AdministrationCompletedNCT01217645Phase 1
• Neurophysiologic Changes in Patients With Bipolar DepressionStatus unknownNCT01213121Phase 4
• Treatment of Maternal Depression in Home Visitation: Mother and Child ImpactsCompletedNCT01212783Not applicable
• Study of Physical Health for Women With Posttraumatic Stress or DepressionCompletedNCT01208844
• Cognitive Behavioral Treatments for Depression in Chronic IllnessCompletedNCT01208428Not applicable
• A Comparison of Cognitive and Dynamic Therapy for Depression in Community SettingsCompletedNCT01207271Not applicable

← Depressive Disorder overview